10657 Results
2

Searching for breakthroughs on multiple fronts

January 25, 2022

The University of Cincinnati's Dr. Timothy Phoenix has received three separate grants from philanthropic organizations and the National Institutes of Health to learn more about the genetic workings of pediatric diffuse midline gliomas, a deadly brain tumor.

3

Breaking down cancer’s defenses

November 19, 2021

University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.

4

How a compound becomes a drug

July 11, 2022

Over decades of ups and downs, the hard work of University of Cincinnati alumnus John Drach paid off when the FDA approved a new drug he helped develop to treat cytomegalovirus.

5

Using bacteria to target cancer treatment

March 28, 2023

Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.

6

UC Brain Tumor Center hosts Clinical Research Retreat

October 6, 2022

The University of Cincinnati Brain Tumor Center (BTC) held its second-annual Clinical Research Retreat on Sept. 30, bringing researchers from around the country together to discuss advancements in neuro-oncology clinical research.

7

UC researcher joins pediatric immunotherapy network

October 19, 2023

The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.

9

The next generation of care

April 15, 2024

University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.